Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Occlusal Splints vs Botulinum Toxin for Bruxism
NCT03891121Completed
- Sponsor
- Ankara University
- Start
- Apr 2018
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of botulinum toxin type A in myofascial pain syndrome (MPS) and temporomandibular disorder (TMD), sponsored by Ankara University. Started Apr 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pain syndrome (MPS)temporomandibular disorder (TMD)
Beyond the preview
Go deeper on NCT03891121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03891121.